体外診断 (IVD) 品質管理の 世界市場

Report Highlights

The global market for in vitro diagnostics quality controls is expected to grow from $1.5 billion in 2024 and is projected to reach $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.8% during the forecast period of 2024 to 2029.

Report Ovewview

Report Scope
This report provides details about the market for in vitro diagnostics quality controls used in checking the in vitro diagnostic devices present in labs, clinics and hospitals. This report will also highlight the current and future market potentiality of in vitro diagnostics quality controls, with a detailed analysis of the competitive environment between companies. Drivers, restraints, opportunities, prevalence or incidence of chronic diseases, and a regulatory scenario assessment will be covered in the current report. The report includes market projections for 2029 and market shares for key players.
Based on test type, the market is segmented into immunodiagnostics, clinical chemistry, hematology and hemostasis, molecular diagnostics, microbiology, and others. Based on products and services, the market is categorized into quality control products, data management solutions and quality assurance services. Based on type of manufacturer, the market is segmented into third-party controls and OEM controls. Based on end users, the market is segmented into hospitals, diagnostic laboratories and academic institutions.
By geographical region, the market has been segmented into North America, Europe, Asia-Pacific, and Rest of the World. Detailed analyses of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, and GCC countries are covered within the regional segments. For market estimates, data will be provided for 2023 as the base year, with estimates for 2024 and forecast value for 2029.
Report Includes
– 40 data tables and 40 additional tables
– An overview of the global market for in vitro diagnostics (IVD) quality controls
– Analysis of global market trends, featuring revenue data for 2021-2023, estimated figures for 2024, and projected CAGRs through 2029
– Evaluation of the current market’s size and revenue growth prospects, along with a market share analysis by test type, manufacturer, product/services, end user and region
– Discussion of market drivers and restraints and other dynamics
– Assessment of the regulatory landscape, including product recalls
– Analysis of the key companies’ market shares, recent M&A activity, acquisitions, joint ventures, partnerships, and patents
– Company profiles,including Abbott, bioMérieux, F. Hoffmann-La Roche Ltd., Siemens Healthineers, and Thermo Fisher Scientific Inc.

Table of Contents

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Summary

Chapter 2 Market and Technology Background

Introduction

Overview

Classification of In Vitro Diagnostics Elements

Importance of In Vitro Diagnostics Quality Control

Regulations

Regulation of IVD products in Different countries

Chapter 3 Market Dynamics

Market Drivers

Rise in the Aging Population and Dependency on Frequent Diagnosis Procedures

Rising Demand for Third-Party Quality Control Products

Rising Incidence of Chronic Disease Cases

Strengthening Clinical Laboratories

Improving the Quality of Point-of-Care Testing

Market Restraints

Challenges for Quality Control Product Packaging

Increases in Shipping Costs or Service Issues

Improper Operation and Maintenance of Laboratory Equipment and Consumables

Market Opportunities

Rise in Home Care Testing Devices

Demand for Point-of-Care (POC) Testing Units

Chapter 4 Emerging Technologies and Developments

Artificial Intelligence

Prioritizing Old IVD Techniques

Automating In-Vitro Diagnostic Devices

Emerging Trends in In Vitro Diagnostics

FDA Approval

Rise in Demand for Personalized Medicine

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown

Market Breakdown by Test Type

Immunodiagnostics

Clinical Chemistry

Hematology

Molecular Diagnostics

Microbiology

Other Test Types

Market Breakdown by Type of Manufacturer

Third-party Controls

ODM Controls

Market Breakdown by Products and Services

Quality Control Products

Data Management Solutions

Quality Assurance Services

Market Breakdown by End User

Diagnostic Laboratories

Hospitals and Clinics

Point-of-Care Centers

Research Institutions

Other End Users

Geographic Breakdown

Market Analysis by Region

North America

Market Size and Forecast

U.S.

Canada

Mexico

Europe

Market Size and Forecast

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia-Pacific

Market Size and Forecast

Japan

China

India

Australia and New Zealand

Rest of Asia-Pacific

Rest of the World

Market Size and Forecast

Brazil

GCC Countries

Rest of the World Countries

Chapter 6 Competitive Intelligence

Introduction

Global Analysis of Company Market Ranking

Agreements, Collaborations and Partnerships

In Vitro Diagnostics Developments and Startups, 2021–2023

Chapter 7 Sustainability

Importance of ESG in the In Vitro Diagnostics Industry

ESG Practices in the In Vitro Diagnostics Industry

Environmental Performance

Social Performance

Governance Performance

Case Studies

BCC Research Viewpoint

Chapter 8 Appendix

Research Methodology

References

Company Profiles

ABBOTT

BD

BIOMÉRIEUX

BIO-RAD LABORATORIES INC.

BIO-TECHNE

DANAHER CORP.

1. HOFFMANN-LA ROCHE LTD.

MICROBIOLOGICS

QUIDELORTHO CORP.

SIEMENS HEATHNIEERS AG

SYSMEX CORP.

THERMO FISHER SCIENTIFIC INC.

List Of Tables

List of Tables

Summary Table : Global Market for In Vitro Diagnostics Quality Controls, by Test Type, Through 2029

Table 1 : Global Market for In Vitro Diagnostics Quality Controls, by Test Type, Through 2029

Table 2 : Global Market for Immunodiagnostics, by Region, Through 2029

Table 3 : Global Market for Clinical Chemistry, by Region, Through 2029

Table 4 : Global Market for Hematology, by Region, Through 2029

Table 5 : Global Market for Molecular Diagnostics, by Region, Through 2029

Table 6 : Global Market for Microbiology, by Region, Through 2029

Table 7 : Global Market for Other Test Types, by Region, Through 2029

Table 8 : Global Market for In Vitro Diagnostics Quality Controls, by Type of Manufacturer, Through 2029

Table 9 : Global Market for Third-party Controls, by Region, Through 2029

Table 10 : Global Market for ODM Controls, by Region, Through 2029

Table 11 : Global Market for In Vitro Diagnostics Quality Controls, by Type of Product and Service, Through 2029

Table 12 : Global Market for Quality Control Products, by Region, Through 2029

Table 13 : Global Market for Serum/Plasma-Based Controls, by Region, Through 2029

Table 14 : Global Market for Whole Blood-Based Controls, by Region, Through 2029

Table 15 : Global Market for Urine-based Controls, by Region, Through 2029

Table 16 : Global Market for Other Quality Control Products, by Region, Through 2029

Table 17 : Global Market for Data Management Solutions, by Region, Through 2029

Table 18 : Global Market for Quality Assurance Services, by Region, Through 2029

Table 19 : Global Market for In Vitro Diagnostics Quality Controls, by End User, Through 2029

Table 20 : Global Market for IVD Quality Controls in Diagnostic Laboratories, by Region, Through 2029

Table 21 : Global Market for IVD Quality Controls in Hospitals and Clinics, by Region, Through 2029

Table 22 : Global Market for IVD Quality Controls in Point-of-Care Centers, by Region, Through 2029

Table 23 : Global Market for IVD Quality Controls in Research Institutions, by Region, Through 2029

Table 24 : Global Market for Other End Users, by Region, Through 2029

Table 25 : Global Market for In Vitro Diagnostics Quality Controls, by Region, Through 2029

Table 26 : North American Market for In Vitro Diagnostics Quality Controls, by Country, Through 2029

Table 27 : European Market for In Vitro Diagnostics Quality Controls, by Country, Through 2029

Table 28 : Asia-Pacific Market for In Vitro Diagnostics Quality Controls, by Country, Through 2029

Table 29 : Rest of the World Market for In Vitro Diagnostics Quality Controls, by Country/Sub-Region, Through 2029

Table 30 : ESG Practices: Environmental Performance

Table 31 : ESG Practices: Social Performance

Table 32 : ESG Practices: Governance Performance

Table 33 : Abbott: Company Snapshot

Table 34 : Abbott: Financial Performance, FY2022 and 2023

Table 35 : Abbott: Product Portfolio

Table 36 : Abbott: News/Key Developments, 2021 and 2022

Table 37 : BD: Company Snapshot

Table 38 : BD: Financial Performance, FY 2022 and 2023

Table 39 : BD: Product Portfolio

Table 40 : BD: News/Key Developments, 2023 and 2024

Table 41 : bioMérieux: Company Snapshot

Table 42 : bioMérieux: Financial Performance, FY 2022 and 2023

Table 43 : bioMérieux: Product Portfolio

Table 44 : bioMérieux: News/Key Developments, 2023

Table 45 : Bio-Rad Laboratories Inc.: Company Snapshot

Table 46 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023

Table 47 : Bio-Rad Laboratories Inc.: Product Portfolio

Table 48 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024

Table 49 : Bio-Techne: Company Snapshot

Table 50 : Bio-Techne: Financial Performance, FY 2022 and 2023

Table 51 : Bio-Techne: Product Portfolio

Table 52 : Bio-Techne: News/Key Developments, 2022 and 2023

Table 53 : Danaher Corp.: Company Snapshot

Table 54 : Danaher Corp.: Financial Performance, FY 2022 and 2023

Table 55 : Danaher Corp.: Product Portfolio

Table 56 : Danaher Corp.: News/Key Developments, 2021-2023

Table 57 : F. Hoffmann-La Roche Ltd.: Company Snapshot

Table 58 : F. Hoffmann-La Roche Ltd.: Financials, FY 2022 and 2023

Table 59 : F. Hoffmann-La Roche Ltd.: Product Portfolio

Table 60 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024

Table 61 : Microbiologics: Company Snapshot

Table 62 : Microbiologics: Product Portfolio

Table 63 : Microbiologics: News/Key Developments, 2022

Table 64 : QuidelOrtho Corp.: Company Snapshot

Table 65 : QuidelOrtho Corp.: Financial Performance, FY 2022 and 2023

Table 66 : QuidelOrtho Corp.: Product Portfolio

Table 67 : QuidelOrtho Corp.: News/Key Developments, 2021-2024

Table 68 : Siemens Healthineers AG: Company Snapshot

Table 69 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023

Table 70 : Siemens Healthineers AG: Product Portfolio

Table 71 : Siemens Healthineers AG: News/Key Developments, 2021-2023

Table 72 : Sysmex Corp.: Company Snapshot

Table 73 : Sysmex Corp.: Financial Performance, FY 2021 and 2022

Table 74 : Sysmex Corp.: Product Portfolio

Table 75 : Sysmex Corp.: News/Key Developments, 2022 and 2023

Table 76 : Thermo Fisher Scientific Inc.: Company Snapshot

Table 77 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023

Table 78 : Thermo Fisher Scientific Inc.: Product Portfolio

Table 79 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023

List Of Figures

List of Figures

Summary Figure : Global Market Shares of In Vitro Diagnostics Quality Controls, by Test Type, 2023

Figure 1 : In Vitro Diagnostics (IVD) Quality Controls Global Market: Market Dynamics

Figure 2 : Elderly Population (Aged 65 and above), by Top Countries, 2022

Figure 3 : Comparison Between Third-Party Controls and Original Equipment Manufacturer Controls

Figure 4 : Global Market Shares of In Vitro Diagnostics Quality Controls, by Test Type 2023

Figure 5 : Global Market Shares of In Vitro Diagnostics Quality Control, by Type of Manufacturer 2023

Figure 6 : Global Market Shares of In Vitro Diagnostics Quality Controls, by Type of Product and Service, 2023

Figure 7 : Global Market Shares of In Vitro Diagnostics Quality Controls, by Type of Quality Control Product, 2023

Figure 8 : Global Market Shares of In Vitro Diagnostics Quality Controls, by End-user, 2023

Figure 9 : Global Market Shares of In Vitro Diagnostics Quality Controls, by Region, 2023

Figure 10 : North American Market Shares of In Vitro Diagnostics Quality Controls, by Test Type, 2023

Figure 11 : North American Market Shares of In Vitro Diagnostics Quality Controls, by Type of Manufacturer, 2023

Figure 12 : North American Market Shares of In Vitro Diagnostics Quality Controls, by Product and Service, 2023

Figure 13 : North American Market Shares of In Vitro Diagnostics Quality Control Products, by Type of Product, 2023

Figure 14 : North American Market Shares of In Vitro Diagnostics Quality Controls, by End User, 2023

Figure 15 : North American Market Shares of In Vitro Diagnostics Quality Controls, by Country, 2023

Figure 16 : European Market Shares of In Vitro Diagnostics Quality Controls, by Test Type, 2023

Figure 17 : European Market Shares of In Vitro Diagnostics Quality Controls, by Type of Manufacturer, 2023

Figure 18 : European Market Shares of In Vitro Diagnostics Quality Controls, by Product and Service, 2023

Figure 19 : European Market Shares of In Vitro Diagnostics Quality Control Products, by Type of Product, 2023

Figure 20 : European Market Shares of In Vitro Diagnostics Quality Controls, by End User, 2023

Figure 21 : European Market Shares of In Vitro Diagnostics Quality Controls, by Country, 2023

Figure 22 : Asia-Pacific Market Shares of In Vitro Diagnostics Quality Controls, by Test Type, 2023

Figure 23 : Asia-Pacific Market Shares of In Vitro Diagnostics Quality Controls, by Type of Manufacturer, 2023

Figure 24 : Asia-Pacific Market Shares of In Vitro Diagnostics Quality Controls, by Product and Service, 2023

Figure 25 : Asia-Pacific Market Shares of In Vitro Diagnostics Quality Control Products, by Type of Product, 2023

Figure 26 : Asia-Pacific Market Shares of In Vitro Diagnostics Quality Controls, by End User, 2023

Figure 27 : Asia-Pacific Market Shares of In Vitro Diagnostics Quality Controls, by Country, 2023

Figure 28 : Rest of World Market Shares of In Vitro Diagnostics Quality Controls, by Test Type, 2023

Figure 29 : Rest of World Market Shares of In Vitro Diagnostic Quality Controls, by Type of Manufacturer, 2023

Figure 30 : Rest of World Market Shares of In Vitro Diagnostics Quality Controls, by Product and Service, 2023

Figure 31 : Rest of World Market Shares of In Vitro Diagnostics Quality Control Products, by Type of Product, 2023

Figure 32 : Rest of World Market Shares of In Vitro Diagnostics Quality Controls, by End User, 2023

Figure 33 : Rest of the World Market Shares of In Vitro Diagnostics Quality Controls, by Country/Sub-Region, 2023

Figure 34 : Global Market Ranking of In Vitro Diagnostics Quality Controls, by Company, 2023

Figure 35 : Snapshot: Key ESG Trends in the In Vitro Diagnostics Industry

Figure 36 : Abbott: Revenue Shares, by Business Unit, FY 2023

Figure 37 : Abbott: Revenue Shares, by Country/Region, FY 2023

Figure 38 : BD: Revenue Shares, by Country/Region, FY 2023

Figure 39 : BD: Revenue Shares, by Business Unit, FY 2023

Figure 40 : bioMérieux: Revenue Shares, by Country/Region, FY 2023

Figure 41 : bioMérieux: Revenue Shares, by Business Unit, FY 2023

Figure 42 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 43 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023

Figure 44 : Bio-Techne: Revenue Shares, by Business Unit, FY 2023

Figure 45 : Bio-Techne: Revenue Shares, by Country/Region, FY 2023

Figure 46 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 47 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023

Figure 48 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023

Figure 49 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023

Figure 50 : QuidelOrtho Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 51 : QuidelOrtho Corp.: Revenue Shares, by Country/Region, FY 2023

Figure 52 : Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2023

Figure 53 : Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2023

Figure 54 : Sysmex Corp.: Revenue Shares, by Business Unit, FY 2022

Figure 55 : Sysmex Corp.: Revenue Shares, by Country/Region, FY 2022

Figure 56 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 57 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
• 免疫療法薬の世界市場 2025-11-12
• 農業におけるAIの世界市場 2025-11-10
• 固体酸化物形燃料電池の技術と世界市場 2025-11-07
• 世界の電気アーク炉市場 2025-11-07

BCC Research  出版レポート一覧